Northwestern Medicine’s women leaders in neurosciences are advancing research and patient care across various neurological subspecialties, from headache disorders to sleep medicine.

The Epitomee capsule, a novel ingestible device for weight management, has shown promising results in clinical trials, with 55.5% of users losing at least 5% of their baseline body weight at 24 weeks.

Primary CNS vasculitis affects an estimated 2.4 cases per 1 million person-years, presenting a significant diagnostic and therapeutic challenge for neurologists and rheumatologists.

Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.

Recent surveys indicate that 53% of physicians report feeling burned out, with female doctors experiencing higher rates than their male counterparts.

Researchers identified the post-fast refeeding period as a distinct state with greater potential for tumor proliferation compared to the fasted or continuously fed state.